The global live cell imaging market was worth $2.35 billion in 2021 and is expected to be worth $5.01 billion by 2030, representing a 9.2% CAGR from 2021 to 2030.
Live-cell imaging, as the name implies, is a technique that involves imaging cells while they are still alive, usually in their growing media. It is a sophisticated imaging technique that provides researchers with real-time spatiotemporal changes in subcellular events, allowing them to understand cellular structures and functions better. Live cell imaging has recently become a necessary analytical tool for addressing pertinent questions in various biological and biomedical sciences, including cancer research, neuroscience, cell biology, developmental biology, and pharmacology.
Technology has altered how scientists and researchers study cellular processes, proteins, molecular interactions, and cell internal structures to understand various biological functions better. As a result, precise information can be obtained through live cell imaging, which is critical for immunology, microbiology, and other fields.
Fluorescent probes play a vital role in various advanced imaging techniques such as time-lapse microscopy, intravital imaging, confocal microscopy, super-resolution microscopy, and fluorescence microscopy. These probes enable scientists to observe and track dynamic cellular processes in real-time, providing valuable insights into the intricate workings of biological systems. Coupled with fluorescence resonance energy transfer (FRET), these probes offer enhanced sensitivity and specificity, enabling precise measurements of molecular interactions. Single-cell imaging and live imaging techniques further contribute to our understanding of cellular behavior, allowing for the observation of individual cells and their responses within complex biological environments.
Market Dynamics
Drivers:
Expanding research and development efforts
Increased investment in research and development is expected to boost market growth. Other factors, such as rising cancer incidence, increased adoption of high-content screening approaches in drug discovery, rising demand for better and faster diagnostic facilities, and technological advancement, are expected to propel the live cell imaging market forward from 2022 to 2030.
Validation of high-content screening techniques
The global live cell imaging market is being driven by the relinquishment of high-content webbing ways, large government backing for cell-grounded exploration, and rising cancer circumstances worldwide. Request actors will profit from using high-content webbing styles for primary webbing and live cell imaging in individualized drugs.
Advancement Technologies
According to a medicine Discovery World Spring bean, nearly 21 of experimenters prefer and use live cell imaging, with 31 planning to do so in the future. Likewise, 38 of the repliers indicated an interest in using live cell kinetic HCS imaging in the future. The capability of any live cell analyzer to automate incubation and image prisoner is the most important point for experimenters. Second, they value the outfit's capability to track live cells. Over the projected period, further outfit technology advancements will likely meet these criteria and increase their mileage.
Restraints:
The high cost of high-content screening systems and a need for more skilled and trained professionals is expected to hamper the live cell imaging market growth.
Key players:
Market Segmentation:
Live Cell Imaging Market, Based on Product
Live Cell Imaging Market, Based on Application
Live Cell Imaging Market, Based on Technology
Live Cell Imaging Market, Based on Regions
-
North America
-
Europe
-
Asia Pacific
-
LAMEA
Regional Analysis
North America is dominated by market share, closely followed by Europe. The region's primary driver is the availability of generous investments and funding for research in this field. The Government of Canada announced USD XX million in funding for the Canada Research Chairs Program in December 2016. This fund was part of a total infrastructure funding package worth more than USD XX million. This program includes projects on live cell imaging in plant development undertaken by McGill University.
Europe also had a significant share due to early technological adoption. The aging population necessitates intensive research into chronic diseases such as cancer, neuron degeneration, and cardiovascular disease. This has benefited stem cell research as well as advanced microscopy. For example, Cancer Research UK and the Welcome Trust are increasingly funding cell and developmental biology research. In December 2016, the trust committed USD XX million to support 14 research centers over the next five years.
Private research institutes and universities are collaborating to make technology more accessible and to produce faster results. Uppsala University published a study in December 2016 demonstrating the use of smartphones in live cell imaging and its feasibility. This eliminates the need for costly equipment and consumables.
Scope of the Report:
|
Report Coverage |
Details |
|
Base year |
2021 |
|
Forecast period |
2022-2030 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.2% |
|
YoY growth (%) |
XX% |
|
Regional analysis |
|
|
Current Market size |
USD 2.35 billion |
|
Companies Covered |
|
User
Tab Content
Introduction
Our market research is an extensive, iterative process that takes into account a combination of primary and secondary research tools with the aim of minimizing deviation and producing the most precise estimate and prediction. For the future course of action, this approach meticulously outlines the actual changes and industry trends. It gives incredibly valuable data that is drawn from the insights and opinions of analysts and professionals. Our papers include in-depth research and analysis based on several factual inputs obtained from expert interviews, accurate data, and local information.
Market Size Estimation
The overall size of the market has been estimated and validated using both top-down and bottom-up methods. The sizes of other market subsegments have also been thoroughly estimated using these methodologies.
In the top-down technique, the market is divided into segments based on the percentage share of each segment. This method assisted in determining the size of each segment's market. The market size of each segment and its sub-segments was then divided into regional market sizes. This Approach helps mainly with the new Product Launch. It uses Multi-variate Regression Model coupled with Vendor based primary research inputs to forecast to the Market Size.
In the Bottom-Up approach, comprehensive study of key players has to be done wherein we add the market size of the major key players to understand the national market size which helps to determine the regional market size and eventually the complete market size. Companies annual report along with data from paid and unpaid resources like reports from government agencies and organizations like world bank provide the data for this approach.
Avail 25% Discount
Report Benefits
-
Free Customization Available
-
30% discount on your next purchase
-
Dedicated account manager
-
Query resolution within 24 hours
-
Permission to print the report